(Reuters Health)—Adults 50 years and older who take tumor necrosis factor inhibitors (TNFi’s) for a range of inflammatory disorders can receive effective protection from shingles… [Read More]
Latest News
Severe COVID-19 May Trigger Autoimmunity
Practical Ways to Manage Cardiovascular Risk in Patients with Psoriatic Arthritis
The Role of ANA Positivity in Patients with RA
Nonserious Infection Rates with Biologics Used to Treat RA
Bechman et al. set out to describe the frequency and predictors of nonserious infections and compare incidence rates across biologic DMARDs. They found all bDMARDs are associated with a greater risk of nonserious infection, with differences observed between agents. Although unmeasured confounding must be considered, the magnitude of effect is large. [Read More]
Experts Share Insights & Advice on Reproductive Health for Patients with Rheumatic Disease
Sponsored Content
Sponsored by Our Lab is Everywhere
Clinical evidence may help patients' changing needs.
See the story behind the moderate to severe RA study that reveals outcomes of one biologic monotherapy.USA-916-82440
LEARN MOREFrom the Current Issue: September 2021
COVID-19 Disproportionately Stymies Women Researchers
Moonshot: Apollo 11, Vaccines & Other Conspiracies
A Look Back at the ACR’s Strong Response to COVID-19
The ACR Responds to CVS Caremark Prior Authorization Changes
Playtex 18 Hour Ultimate Lift Support Wirefree Bra (4745B)
The ACR sent a letter to CVS Caremark detailing how recent updates to its prior authorization forms for many biologic drugs are increasing the paperwork burden for rheumatology practices and hurting patients’ timely access to treatment. [Read More]